Thermo Fisher Scientific Inc.
Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%
Thermo Fisher Scientific Segment Income Margin by Year
Segment Income Margin — Laboratory Products & Biopharma Services (%)
Thermo Fisher Scientific Segment Income Margin: 14.0% in FY2025, up 0.7 pts from a year earlier.
Where the FY2025 figure comes from
“LPBS: Segment income margin 13.0% 13.8% 14.5% 14.5% 14.0% 12.9% 14.0% 15.5%”
Source: Q3 2026 Reconciliation of Financial Information ↗
Reported in IR Financial Reconciliation Package & SEC MD&A.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Segment Income Margin — Laboratory Products & Biopharma Services (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 14.0% | +0.7 pts | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2024 | Dec 31, 2024 | 13.3% | -1.3 pts | Q4 & FY2025 Reconciliation of Financial Information ↗ |
| FY2023 | Dec 31, 2023 | 14.6% | +1.8 pts | Q4 & FY2024 Reconciliation of Financial Information ↗ |
| FY2022 | Dec 31, 2022 | 12.8% | +0.4 pts | SEC Form 8-K (8k_2023Q4, filed 2024-01-31) ↗ |
| FY2021 | Dec 31, 2021 | 12.4% | – | SEC Form 10-K (10k_2022, filed 2023-02-23) ↗ |
Cite this data
StockData. (2026). Thermo Fisher Scientific Segment Income Margin (%), annual FY2021–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/seg-margin-lpbs
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.